Sanofi to Buy Vigil Neuroscience for About $470 Million
Sanofi to Buy Vigil Neuroscience for About $470 Million · The Wall Street Journal

In This Article:

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer’s disease to the French pharmaceutical company’s pipeline.